Risks of Tramadol and Gabapentin Use for Pain
Risks of Tramadol and Gabapentin Use for Pain
February 2, 2026 (Issue: 1747)
Tramadol (Ultram, and others) and gabapentin
(Neurontin, and others) are increasingly being
prescribed for treatment of chronic pain despite reports
of serious adverse events associated with their use.
Both drugs are touted as safer and less...more
- AE Strahan et al. Trends in dispensed gabapentin prescriptions in the United States, 2010 to 2024. Ann Intern Med 2025; 178:1816. doi:10.7326/annals-25-01750
- KR Crews et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin Pharmacol Ther 2012; 91:321. doi:10.1038/clpt.2011.287
- Opioids for pain. Med Lett Drugs Ther 2022; 64:193.
- Y-JJ Wei et al. Risk of seizure associated with concomitant use of tramadol and antidepressants in older nursing home residents. Neurology 2025; 105:e214270. doi:10.1212/wnl.0000000000214270
- SN Oh et al. Tramadol use and incident dementia in older adults with musculoskeletal pain: a population-based retrospective cohort study. Sci Rep 2024; 14:23850. doi:10.1038/s41598-024-74817-3
- JA Barakji et al. Tramadol versus placebo for chronic pain: a systematic review with meta-analysis and trial sequential analysis. BMJ Evid Based Med 2025 Oct (epub). doi:10.1136/bmjebm-2025-114101
- A Shah et al. Characteristics of initial prescription episodes and likelihood of long-term opioid use – United States, 2006-2015. MMWR Morb Mortal Wkly Rep 2017; 66:265. doi:10.15585/mmwr.mm6610a1
- CA Thiels et al. Chronic use of tramadol after acute pain episode: cohort study. BMJ 2019; 365:l1849. doi:10.1136/bmj.l1849
- M Russo et al. Gabapentin—friend or foe? Pain Pract 2023; 23:63. doi:10.1111/papr.13165
- AG McNeilage et al. Healthcare practitioner and other professionals' perspectives on gabapentinoid misuse and dependence: a systematic review of qualitative studies. Eur J Pain 2025; 29:e70116. doi:10.1002/ejp.70116
- JP Rissardo et al. Gabapentin-associated movement disorders: a literature review. Medicines (Basel) 2023; 10:52. doi:10.3390/medicines10090052
- Y Pan et al. Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. Cardiovasc Diabetol 2022; 21:170. doi:10.1186/s12933-022-01610-9
- Y Pan et al. Association of adverse cardiovascular events with gabapentin and pregabalin among patients with fibromyalgia. PLoS One 2024; 19:e0307515. doi:10.1371/journal.pone.0307515
- EE Park et al. Initiation of pregabalin vs gabapentin and development of heart failure. JAMA Netw Open 2025; 8:e2524451. doi:10.1001/jamanetworkopen.2025.24451
- NB Eghrari et al. Risk of dementia following gabapentin prescription in chronic low back pain patients. Reg Anesth Pain Med 2025 Jul 10 (epub). doi:10.1136/rapm-2025-106577
- AA Rahman et al. Gabapentinoids and risk for severe exacerbation in chronic obstructive pulmonary disease: a population-based cohort study. Ann Intern Med 2024; 177:144. doi:10.7326/m23-0849
- LS Gold et al. Adverse respiratory events during treatment with gabapentin and opioids among older adults with spine-related conditions: a propensity-matched cohort study in the US Medicare population. Spine J 2025; 25:2096. doi:10.1016/j.spinee.2025.03.014
- LS Gold et al. Mortality after concurrent treatment with gabapentin and opioids in older adults with spine diagnoses. Pain 2025; 166:e51. doi:10.1097/j.pain.0000000000003448
- MA Corriere et al. Concurrent gabapentin and opioid use and risk of mortality in Medicare recipients with non-cancer pain. Clin Pharmacol Ther 2023; 114:1050. doi:10.1002/cpt.3019
- T Gomes et al. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med 2017; 14:e1002396. doi:10.1371/journal.pmed.1002396
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to
The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App
- FREE online per issue CME/CE
Purchase this article:
Title: Risks of Tramadol and Gabapentin Use for Pain
Article code: 1747d
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
